Impli is a pioneering biotechnology company dedicated to revolutionizing accessibility and efficacy in the world of in vitro fertilization (IVF). Our breakthrough innovation, a biosensing platform, a novel combination of electronics and subdermal biosensors, allows for the continuous monitoring of hormones crucial for egg retrieval, embryo transfer, and pregnancy development. Leveraging NFC technology, the device communicates seamlessly with modern smartphones, providing instant readings of three vital hormone levels. This capability eliminates the need for frequent blood draws, offering a convenient and accurate approach to enhancing IVF outcomes.